Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Headquarters
3rd-4th Floor Hijau Arkadia Office Building - Tower A, Jl. Letjen. T.B. Simatupang Kav. 88
South Jakarta; Jakarta; Map
Postal Code: 62516
Tel: (+62)-021-782
Fax: (+62)-021-782

Full name: Otsuka Indonesia, Pt

Status: Non-Listed
Legal Form: Limited Liability Partnership
Operational Status: Operational
EMISid: 3112324
DUNS: 728705872
ID - REG: AHU-12764.40.22
Incorporation Date: 1974

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Company Description

PT Otsuka Indonesia is engaged in pharmaceutical industry. The head office is located in the commercial area in Jakarta. While the factory is in Lawan, Malang, East Java. Currently the Company has 5 categories of product that they produce, i.e. Clinical Nutrition products, Therapeutics Drugs, Medical Equipment, Medical Foods and IV Solution. Other than to comply the domestic market demand, the product that they produces have penetrate the market in 15 countries around the world like USA, Middle East,…

More

Basic Information

Total Employees:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Key Executives

Commissioner

Ownership Details

Otsuka Pharmaceutical Co., Ltd., Japan
76.63%

Key Stats

Select Items to chart them. 2014 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss)
Total assets 752,848,000
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: D&B Indonesia, EMIS Company Database.

Financials

Competitors - Indonesia

IDR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2014
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest